You have 9 free searches left this month | to do more

TAK-906

TAK 906 is a drug used to treat Healthy Volunteers and Japanese Healthy Adult Male Participants. TAK 906 is not being actively studied and prior, has been studied in 2.

Top SponsorsTop SitesTop Investigators
TakedaCelerion
Millennium Pharmaceuticals, Inc.Sekino Clinical Pharmacology Clinic
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
T
Bioavailability and Food Effect Study of Two Formulations of TAK-906 - 2022
Withdrawn
  • Healthy Volunteers
  • TAK-906
  • Tempe, Arizona
    Celerion
2022-03-22
Mar 22, 2022
T
Phase 1 TAK-906 Single and Multiple Ascending Dose Study in Japanese Healthy Male Participants - 2017
Completed
Has Results
  • Japanese Healthy Adult Male Participants
  • TAK-906
  • TAK-906 Placebo
  • Toshima, Tokyo, Japan
    Sekino Clinical Pharmacology Clinic
2020-12-18
Dec 18, 2020
M
A Study to Evaluate the Effect of Single-Dose Intravenous Rifampin as a Prototypic Inhibitor of Organic Anion Transporting Polypeptide (OATP) 1B1 and OATP1B3 on the Single-Dose Pharmacokinetics (PK) of Oral TAK-906 in Healthy Adult Participants - 2019
Completed
Has Results
  • Healthy Volunteers
  • Lincoln, Nebraska
    Celerion
2020-11-13
Nov 13, 2020